Boston Scientific Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.2% | +4.4% | +1.2% | +2.6% | +3.5% | +1.9% | +3.5% | +2.8% | +2.3% | +1.6% | +2.0% | |
| – | +0.2% | +25.7% | +9.8% | -2.6% | -21.0% | +6.0% | -2.9% | +12.8% | +9.4% | -1.3% | -8.2% | |
| – | -9.1% | +169.2% | +25.1% | -14.1% | -83.5% | +75.1% | -26.3% | +138.8% | +60.4% | -25.5% | -64.6% | |
| – | -9.1% | +169.2% | +25.1% | -14.1% | -83.5% | +75.1% | -26.3% | +138.8% | +60.4% | -25.5% | -64.6% | |
| – | +6.0% | +3.4% | +4.2% | +4.2% | +2.3% | +5.3% | +4.5% | +0.5% | +3.5% | +3.5% | +0.7% | |
| – | +3.3% | +3.1% | +1.8% | +5.6% | +2.1% | +2.0% | -0.2% | +2.1% | +0.8% | +5.9% | +3.8% | |
| – | – | – | – | – | +7.0% | +2.5% | +3.0% | +8.5% | +4.9% | – | – | |
| – | +5.7% | -0.2% | +0.3% | +4.4% | +13.7% | +1.5% | +4.2% | +0.8% | +0.4% | +1.4% | +0.6% | |
| – | +2.6% | -2.8% | -7.2% | +6.2% | +16.2% | -1.8% | +10.6% | -1.4% | -2.0% | +0.6% | -2.0% | |
| – | +4.6% | +5.7% | 0.0% | +3.8% | +1.6% | +1.7% | +6.8% | +0.9% | +0.6% | -5.0% | +9.8% | |
| – | +7.7% | -0.3% | +13.4% | +6.0% | +8.3% | -21.0% | +2.6% | +2.7% | +2.1% | -16.0% | +40.6% | |
| – | +3.5% | +104.3% | +45.6% | +4.6% | +7.6% | -56.3% | -38.2% | +0.6% | -19.5% | -89.5% | +4,068.3% | |
| – | +1.4% | -2.2% | -1.6% | +0.1% | +5.8% | +4.6% | -4.2% | +4.2% | +14.2% | -0.3% | +7.9% | |
| – | +2.1% | +11.3% | -5.7% | +2.7% | -4.2% | +17.7% | +5.5% | +0.1% | +1.3% | -2.5% | -0.7% | |
| – | +2.1% | +3.3% | +2.2% | +1.7% | +5.1% | +2.0% | +0.9% | +4.4% | +3.6% | +6.7% | -3.6% | |
| – | +160.0% | +60.4% | +24.7% | +28.6% | +26.9% | +25.2% | +23.8% | +18.2% | +13.7% | +24.1% | +13.1% | |
| – | +0.1% | +0.3% | +0.2% | +0.2% | +0.2% | +0.2% | +0.0% | +0.1% | +0.0% | -0.1% | -0.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.